knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 18:54:09 - browse：35

Steven Pearson — ICER President Steven D. Pearson Craig F. Walker/The Boston Globe

Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. But a meeting Thursday at the Massachusetts Institute of Technology may prove to be the exception to that rule.

Patients Rising Now, an advocacy group that says it promotes transparency in health care and that is a fierce opponent of ICER’s, is expected to face off with the self-professed “watchdog of drug pricing” as it reviews three drugs for Duchenne muscular dystrophy.

Dozens of Duchenne patients and their families — many of whom also express concern that ICER’s review could undermine insurers’ already tepid interest in the treatments — are also expected to be in attendance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： General Catalyst, Summa Health deal will turn on physician buy

WSS

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Caregivers of transplant patients call for more support, training

The SUPPORT Act is critical to fighting the opioid crisis

HHS names first

FDA drug safety: Singulair case shows systemic surveillance flaws

Wikipedia

knowledge

focus

The cancer drug shortage isn’t new — and neither are the solutions

FDA drug safety: Singulair case shows systemic surveillance flaws

Activists slam private health insurers over coverage restrictions

New Ultima Genomics DNA sequencer can read genome for $100

Novavax promises a turnaround & Lilly roils the obesity market

Apple Vision Pro: A first look at health apps on the new VR headset

The high cost of giving birth even with insurance

Risky weight loss products often used by teens globally, per study

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Risky weight loss products often used by teens globally, per study

leisure time

Cognito secures funding to test medical device for Alzheimer's

New Medicare drug pricing powers could soon be upended in court

ARCH Venture Partners is raising $3 billion for a life sciences fund

Designating disabled people as health disparity population is crucial

New menopause drug shows promise in relief for hot flashes

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

leisure time

entertainment

Wikipedia

Wikipedia